Katja Välimäki

485 total citations
16 papers, 296 citations indexed

About

Katja Välimäki is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katja Välimäki has authored 16 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katja Välimäki's work include Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers) and Cancer Mechanisms and Therapy (2 papers). Katja Välimäki is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers) and Cancer Mechanisms and Therapy (2 papers). Katja Välimäki collaborates with scholars based in Finland, Sweden and Estonia. Katja Välimäki's co-authors include Teijo Pellinen, Olli Kallioniemi, Sami Blom, Riku Turkki, Lassi Paavolainen, Dmitrii Bychkov, Annabrita Hemmes, Johan Lundin, Oscar Brück and Olli Dufva and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Scientific Reports.

In The Last Decade

Katja Välimäki

15 papers receiving 295 citations

Peers

Countries citing papers authored by Katja Välimäki

Since Specialization

Citations

This map shows the geographic impact of Katja Välimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Välimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Välimäki more than expected).

Fields of papers citing papers by Katja Välimäki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Välimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Välimäki. The network helps show where Katja Välimäki may publish in the future.

Co-authorship network of co-authors of Katja Välimäki

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Välimäki. A scholar is included among the top collaborators of Katja Välimäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Välimäki. Katja Välimäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities 2025 ·Cell Death Discovery ·(unknown), Astrid Murumägi, Mariliina Arjama, Katja Välimäki, (unknown), Tuomas Mirtti, Antti Rannikko, Teijo Pellinen, Daniela Ungureanu, Olli Kallioniemi	0
2	Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma 2024 ·Communications Biology ·(unknown), Pauliina Kallio, (unknown), (unknown), Romika Kumari, (unknown), Katja Välimäki, (unknown), Pekka Ellonen, Teijo Pellinen, Caroline A. Heckman, Harri Mustonen, Pauli Puolakkainen, Kari Alitalo, Olli Kallioniemi, Tuomas Mirtti, Antti Rannikko, Vilja Pietiäinen, Hanna Seppänen	1
3	ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity 2023 ·Cell Death Discovery ·(unknown), (unknown), Juuli Raivola, Kari Salokas, Kaiyang Zhang, Markku Varjosalo, Teijo Pellinen, Katja Välimäki, (unknown), Synnöve Staff, Sampsa Hautaniemi, Astrid Murumägi, Daniela Ungureanu	10
4	Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer 2022 ·Cancer Research Communications ·Teijo Pellinen, (unknown), Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, (unknown), (unknown), Stig Nordling, Olli Kallioniemi, Antti Rannikko, Tuomas Mirtti	6
5	Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features 2022 ·JNCI Journal of the National Cancer Institute ·Teijo Pellinen, Lassi Paavolainen, (unknown), (unknown), Carina Strell, Artur Mezheyeuski, Max Backman, Linnéa La Fleur, Oscar Brück, Jonas Sjölund, Erik Holmberg, Katja Välimäki, Hans Brunnström, Johan Botling, (unknown), Olli Kallioniemi, Patrick Micke, Arne Östman	38
6	Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma 2022 ·Frontiers in Oncology ·(unknown), Mikko I. Mäyränpää, Lassi Paavolainen, Juuso Paajanen, Katja Välimäki, Eva Sutinen, Henrik Wolff, Jari Räsänen, Olli Kallioniemi, Marjukka Myllärniemi, Ilkka Ilonen, Teijo Pellinen	5
7	E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models 2021 ·Molecular Oncology ·Jarle Bruun, Peter W. Eide, Christian H. Bergsland, Oscar Brück, Aud Svindland, Mariliina Arjama, Katja Välimäki, Merete Bjørnslett, Marianne G. Guren, Olli Kallioniemi, Arild Nesbakken, Ragnhild A. Lothe, Teijo Pellinen	9
8	High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma 2021 ·Translational Oncology ·(unknown), Mariliina Arjama, Siru Mäkelä, (unknown), Katja Välimäki, (unknown), (unknown), Daniela Ungureanu, Olli Kallioniemi, Astrid Murumägi, Micaela Hernberg	4
9	High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma 2021 ·The Journal of Pathology Clinical Research ·(unknown), Juuso Paajanen, Henrik Wolff, Ilkka Ilonen, Eva Sutinen, Katja Välimäki, Arne Östman, Sisko Anttila, Eeva Kettunen, Jari Räsänen, Olli Kallioniemi, Marjukka Myllärniemi, Mikko I. Mäyränpää, Teijo Pellinen	8
10	Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival 2020 ·Blood Advances ·Oscar Brück, Olli Dufva, Helena Hohtari, Sami Blom, Riku Turkki, Mette Ilander, Panu E. Kovanen, Céline Pallaud, Pedro Marques Ramos, Hanna Lähteenmäki, Katja Välimäki, (unknown), António J. M. Ribeiro, Olli Kallioniemi, Kimmo Porkka, Teijo Pellinen, Satu Mustjoki	44
11	Abstract 2945: Clinical implementation of precision systems oncology in the treatment of ovarian cancer based on ex-vivo drug testing and molecular profiling 2019 ·Cancer Research ·Astrid Murumägi, Daniela Ungureanu, Suleiman A. Khan, Akira Hirasawa, Mariliina Arjama, Katja Välimäki, (unknown), Wilhelmiina Niininen, Ashwini Kumar, Samuli Eldfors, Teijo Pellinen, Vilja Pietiäinen, (unknown), Riitta Koivisto-Korander, Johanna Tapper, Mikko Loukovaara, Tero Aittokallio, Ralf Bützow, Olli Kallioniemi	2
12	Abstract 2945: Clinical implementation of precision systems oncology in the treatment of ovarian cancer based on ex-vivo drug testing and molecular profiling 2019 ·Astrid Murumägi, Daniela Ungureanu, Suleiman A. Khan, Akira Hirasawa, Mariliina Arjama, Katja Välimäki, (unknown), Wilhelmiina Niininen, Ashwini Kumar, Samuli Eldfors, Teijo Pellinen, Vilja Pietiäinen, (unknown), Riitta Koivisto-Korander, Johanna Tapper, Mikko Loukovaara, Tero Aittokallio, Ralf Bützow, Olli Kallioniemi	2
13	ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer 2018 ·Scientific Reports ·Teijo Pellinen, Sami Blom, (unknown), Katja Välimäki, John-Patrick Mpindi, Hind Azegrouz, Raffaele Strippoli, (unknown), (unknown), (unknown), Riku Turkki, Yinhai Wang, Miguel Sánchez‐Álvarez, Stig Nordling, (unknown), Tuomas Mirtti, Antti Rannikko, Marı́a C. Montoya, Olli Kallioniemi, Miguel Á. del Pozo	27
14	Combined epithelial marker analysis of tumour budding in stage II colorectal cancer 2018 ·The Journal of Pathology Clinical Research ·(unknown), Sami Blom, Riku Turkki, Katja Välimäki, Samu Kurki, Harri Mustonen, Caj Haglund, Olli Carpén, Olli Kallioniemi, Eija Korkeila, Jari Sundström, Teijo Pellinen	22
15	Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis 2017 ·Scientific Reports ·Sami Blom, Lassi Paavolainen, Dmitrii Bychkov, Riku Turkki, (unknown), Annabrita Hemmes, Katja Välimäki, Johan Lundin, Olli Kallioniemi, Teijo Pellinen	117
16	Abstract 207: Caveolin-1 drives oncogenic TGFβ effects in prostate cancer: in vitro mechanistic insights integrated with systems pathology visualization in primary tumor samples 2015 ·Cancer Research ·Teijo Pellinen, Sami Blom, (unknown), Katja Välimäki, John-Patrick Mpindi, Antti Rannikko, Raffaele Strippoli, Marı́a C. Montoya, Hind Azegrouz, Tuomas Mirtti, (unknown), Olli Kallioniemi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact